Clinical Trials Browser

Phase NA × tislelizumab × Other solid neoplasm × Clear all

NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

Phase NA Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor